Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-κB and phosphatidylinositol 3-kinase

Endocrinology

Volumn 142, Issue 1, 2001, Pages 147-156

  Jeay, Sébastien ^a   Sonenshein, Gail E ^b   Kelly, Paul A ^a   Postel Vinay, Marie Catherine ^a   Baixeras, Elena ^a,c  

^a INSERM   (France)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVATION; GENE EXPRESSION; HORMONE ACTION; IMMUNOBLOTTING; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0035111272     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7892     Document Type: Article

References (56)

1. Evidence for involvement of the growth hormone receptor-associated tyrosine kinase in actions of growth hormone
2. JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone
3. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation
4. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases1 and 2
5. Insulin receptor substrate-1 enhances growth hormone-induced proliferation
6. Cytokine signaling for proliferation, survival, and death in hematopoietic cells
7. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
8. PI-3-kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes
9. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes
10. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase
11. Prolactin, growth hormone, and insulin-like growth factor-I in the immune system
12. Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: Relation with age and GH-binding protein
13. Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor
14. Growth hormone prevents apoptosis through activation of NF-κB in interleukin-3-dependent Ba/F3 cell line
15. Rel/NF-κB transcription factors and the control of apoptosis
16. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
17. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway
18. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase-β
19. Role of the IkappaB kinase complex in oncogenic ras- and raf-mediated transformation of rat liver epithelial cells
20. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NF-κB activation in primary hippocampal neurons
21. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis
22. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival
23. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
24. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line
25. Cancer cell cycles
26. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation
27. Oncogenic activity of the c-Myc protein requires dimerization with Max
28. Phosphorylation of human IκB-α on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli
29. The proline-rich region of the GH receptor is essential for JAK2 phosphorylation, activation of cell proliferation, and gene transcription
30. Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas
31. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter
32. 1 cyclin-dependent kinases
33. 1 growth arrest of murine B-cell lymphomas
34. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
35. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells
36. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
37. p27Kip1 overexpression causes apoptotic death of mammalian cells
38. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
39. 2 arrest after DNA damage
40. 2/M-phase transition
41. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression
42. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21
43. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes
44. Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity
45. Growth hormone attenuation of epidermal growth factor-induced mitogenesis
46. Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts
47. 1
48. l-to-S-phase transition
49. Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling
50. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
51. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
52. Human growth hormone induces and maintains c-myc gene expression in Nb2 lymphoma cells
53. Growth hormone stimulates sequential induction of c-myc and insulin-like growth factor I expression in vivo
54. The myc oncogene: Its role in transformation and differentiation
55. Effects of c-myc expression on cell cycle progression
56. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells